Anlon Healthcare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Promoter and Promoter Group of Anlon Healthcare Limited have filed an annual disclosure confirming that they have NOT created any encumbrance (pledge) on their shares, directly or indirectly, at any time during the financial year 2025-2026. The filing covers 19 entities including individual promoters and promoter group entities such as Anlon Chemical Research Organization, Anlon Lifescience Private Limited, and Advintel Medicare Private Limited. This is a negative confirmation filed under Regulation 31(4), which requires promoters to disclose details of any share pledges created during the year.
No encumbrance on promoter shares is a positive signal for investors as it means the promoter holdings are not at risk of being invoked or sold due to loan defaults, reducing downside risk for minority shareholders.